Corona Remedies’ IPO is scheduled to debut on the stock exchanges today, December 15, following strong investor demand during ...

Corona Remedies shares surge 41% on listing day, debuting at a significant premium amid strong investor demand and confidence ...

Arun Kejriwal, Founder of Kejriwal Research and Investment Services, believes that the issue is expected to get benefit of the positive trends in the secondary market.

Corona Remedies Share Price, IPO Listing, GMP Live Updates: Corona Remedies is all set to hit the secondary market, after the ...

Corona Remedies made a remarkable debut on the stock market, opening with a significant premium. The company's Rs 655-crore ...

On the BSE, Corona Remedies debuted at Rs 1,452, a 36.72% premium.

Corona Remedies Ltd made a spectacular stock market debut on Monday with shares of the drugmaker that counts private equity ...

Shares of Corona Remedies posted a remarkable listing, rising more than 35% on debut, reflecting robust investor demand and ...

Investor participation was enthusiastic across all categories. Overall, the issue was subscribed to 144.5 times, driven ...

Corona Remedies’ shares made a strong debut on the stock market, gaining 36.72 per cent over its IPO price. The pharma ...

In this Market Closing Show, Business Today and India Today Television anchor Sakshi Batra discusses the day's market action, ...

The Rs 655.37-crore initial public offering (IPO) of Crorona Remedies mobilised Rs 195 crore from anchor investors.